Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Global Circulating Tumor Cells (CTC) Market Size Will Reach USD 30.78 Billion By 2029, at a CAGR of 14.9%: Polaris Market Research

Polaris Market Research Logo

News provided by

Polaris Market Research

Apr 13, 2022, 09:30 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, April 13, 2022 /PRNewswire/ -- Polaris Market Research recently published a research report on "Circulating Tumor Cells Market Share, Size, Trends, Industry Analysis Report, By Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis); By Application (Clinical/Liquid Biopsy, Research); By Product; By Specimen; By Region; Segment Forecast, 2022 - 2029" in its research database.

According to recent research study published by Polaris Market Research, the global circulating tumor cells (CTC) market size is expected to register a CAGR of 14.9% and revenue is expected to increase from USD 10.68 Billion in 2021 to reach USD 30.78 Billion by 2029.

What is Circulating Tumor Cells? How Big is Circulating Tumor Cells Market Size?

  • Overview

Tumor cells refer to the cancer cells shed into the lymphatic system in the bloodstream of cancer patients. When these cells circulate over the body through blood circulation, then it is called circulating tumor cells. Cancer is the second leading cause of death across the globe. Cancer is a disease in which abnormal cell grows in the body and spread to other parts of the body. The major types of cancer are lung, prostate, colorectal, stomach, liver, and breast cancer. Circulating tumor cells (CTC) has the potential to metastasize to other parts of the body and develop new tumors in different tissues or organs.

Circulating tumor cells (CTC) detection is an easy process as it doesn't require additional intervention like the removal of biopsies from the patients. CTCs are the essential tool for cancer diagnosis. Circulating tumor cells (CTCs) can exist in different phenotypes, including epithelial, mesenchymal, stem cell-like, or mixed.  Cancer stem cells (CSCs) are cancer cells that have characteristics related to normal stem or progenitor cells. Both circulating tumor cells and cancer stem cells can be used to detect patients who are at higher risk of cancer relapse.

Request Sample Copy of "Circulating Tumor Cells Market" Research Report @ https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market/request-for-sample

Key Questions Answered in The Report Includes:

  • What is the current circulating tumor cells market size?
  • How will the global circulating tumor cells market change over the forecast period, and what will be the market size in the upcoming years?
  • What are the driver's restraints associated with the market, and how do these factors affect the dynamics over the forecast period?
  • What are growth areas within the global circulating tumor cells market space?
  • How is the market sub-categorized, and which are the leading segments?
  • What strategies are the market players adopting?

Top Companies in Circulating Tumor Cells Market Are:

  • AVIVA Biosciences BioCEP Ltd
  • BIOCEPT Inc.
  • BioFluidica
  • Biolidics Limited
  • Bio-Techne Corporation
  • Canopus Bioscience Ltd.
  • Creativ MicroTech Inc.
  • Epic Sciences
  • Fluxion Biosciences Inc.
  • Greiner Bio-One International GmbH
  • Ikonisys Inc
  • IVDiagnostics
  • LineaRx Inc.
  • Vitatex Inc.
  • LungLife AI Inc.
  • Menarini Silicon Biosystems
  • Miltenyi Biotec
  • Precision for Medicine
  • QIAGEN
  • ScreenCell
  • STEMCELL Technologies Inc.
  • Sysmex Corporation

Request for Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market/request-for-discount-pricing

Circulating Tumor Cells Market: Key Driving Factors:

Technological developments in chip technology and rising R&D on circulating tumor cells technology by several government bodies are the key factors driving the market growth. The increase in the number of cancer patients across the globe, followed by the increasing potential of circulating tumor cells (CTCs) in diagnosis and treatment, is also expected to aid the market growth over the forecast period. Also, the rising funding for R&D activities to develop cancer diagnosis techniques has boosted the market. Also, growing preference about minimally invasive diagnostic methods and rising awareness about cancer has led to an increase in demand for preventive medicines. This factor is fueling the market growth.

Directly Purchase a copy of report with TOC @ https://www.polarismarketresearch.com/checkouts/7811

Circulating Tumor Cells Market: Scope of Report

Report Attribute

Details

Market Outlook for 2029

USD 30.78 Billion

Market Size 2021 Value

USD 10.68 Billion

Expected CAGR Growth

14.9% from 2022 - 2029

Base Year

2021

Forecast Year

2022 - 2029

Top Market Players

AVIVA Biosciences BioCEP Ltd, BIOCEPT, Inc., BioFluidica, Biolidics Limited, Bio-Techne Corporation, Canopus Bioscience Ltd., Creativ MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio-One International GmbH, Ikonisys Inc, IVDiagnostics, LineaRx, Inc. (Vitatex, Inc.), LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec, Precision for Medicine, QIAGEN, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation.

Segments Covered

By Technology, By Application, By Product, By Specimen, By Region

Customization Options

Customized purchase options are available to meet your research needs. Explore customized purchase options

Also Read, Press Release on Circulating Tumor Cells Market Size Worth $30.78 Billion By 2029 | CAGR: 14.9%

Circulating Tumor Cells Market: Report Segmentation

  • By Insight by Technology

Based on technology, the circulating tumor cells detection & enrichment methods segment held the largest market share in 2021. The rising development of different methods for enrichment of circulating tumor cells in cancer detection would positively favor the market growth over the forecast period. Also, positive or negative advancements in circulating tumor cells based on biological properties are anticipated to lead the market growth.

  • By Insight by Product

On the basis of product, the devices market segment led the market with the largest revenue share in the global circulating tumor cells market. This growth can be attributed to the introduction of fabricated glass microchips to tackle the challenges, and enhanced technical completeness for mass production are the key factors expected to accelerate growth in this segment.

  • By Insight by Specimen

On the grounds of the specimen segment, the blood specimen segment of the circulating tumor cells market held the largest market revenue share in 2021. A high concentration of specimen type in blood samples causes the highest penetration of this specimen type. Moreover, the introduction of high throughput techniques, which has led to accelerating the detection of genome variation among these cells is further significantly boosting the segment growth.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market/inquire-before-buying

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Geographic Overview: Circulating Tumor Cells Market

North America dominated the market with the largest market share due to the well-established healthcare infrastructure and addition of advanced diagnostic technologies.  The demand for the circulating tumor cells in the U.S., is surging due to the rising prevalence of cancer diseases in the country. These manufacturers are adopting various strategies to improve their footprint in the market.

Browse the Detail Report "Circulating Tumor Cells Market Share, Size, Trends, Industry Analysis Report, By Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis); By Application (Clinical/Liquid Biopsy, Research); By Product; By Specimen; By Region; Segment Forecast, 2022 - 2029" with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market 

For Additional Information OR Media Enquiry, Please Mail Us At: [email protected]

The market is primarily segmented on the basis of technology, application, product, specimen, and region.

Circulating Tumor Cells Market: By Technology Outlook

  • Circulating Tumor Cells Detection & Enrichment Methods
    • Immunocapture
    • Size-based Separation
    • Density-based Separation
    • Combined Methods
  • Circulating Tumor Cells Direct Detection Methods
    • SERS
    • Microscopy
    • Others
  • Circulating Tumor Cells Analysis

Circulating Tumor Cells Market: By Application Outlook

  • Clinical/ Liquid Biopsy
  • Research

Circulating Tumor Cells Market: By Product Outlook

  • Kits & Reagents
  • Blood Collection Tubes
  • Devices or Systems

Circulating Tumor Cells Market: By Specimen Outlook

  • Blood
  • Bone Marrow
  • Other Body Fluids

The Reader Will Find the Following Fundamental Factors

  • Analysis of the current and future structure of the global circulating tumor cells market.
  • Analysis of the consumption patterns.
  • The international business environment, reasons for gaps, and initiatives are discussed.
  • Product applications and types are suggested.
  • The products or goods and consumption in a particular country and region are given.
  • The forecasts for the anticipated period are mentioned.
  • Barriers and hurdles in the global circulating tumor cells market that the players are facing are highlighted.

Browse More Related Reports:

  • Medical Exoskeleton Market Share, Size, Trends, Industry Analysis Report, By Component (Hardware, and Software); By Type (Powered, and Passive); By Application (Spinal Cord Injury, Multiple Sclerosis, Cerebral Palsy, Stroke, and Others); By End-Use; By Region; Segment Forecast, 2022 – 2030
  • Pharmaceutical Processing Seals Market Share, Size, Trends, Industry Analysis Report, By Type (O-rings, Gaskets, Lip seals, D seals, and Others); By Material (Metals, PTFE, Silicone, Nitrile Rubber, EPDM, FKM, FFKM, UHMWPE, and PU); By Application (Manufacturing Equipment, R&D, Quality Control, Packaging Equipment, Others); By Region; Segment Forecast, 2022 – 2030
  • Anatomic Pathology Market Share, Size, Trends, Industry Analysis Report, By Product; By Application (Disease Diagnosis, Drug Discovery and Development, Others); By End-Use (Hospitals, Research Laboratories, Diagnostic Laboratories, Others), By Region; Segment Forecast, 2022 – 2030
  • Automated Suturing Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Disposable, Reusable); By End-Use (Hospitals, Ambulatory Surgical Centers, Others); By Application; By Region; Segment Forecast, 2022 – 2030
  • Dental Articulators Market Share, Size, Trends, Industry Analysis Report, By Product Type (Fully-Adjustable Articulators, Semi-Adjustable Articulators, Non-Arcon Articulators, Arcon Articulators, Non-Adaptable Articulators, Virtual Articulators); By Material Type; By End-Use; By Region; Segment Forecast, 2022 - 2030

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727 
Email: [email protected] 
Web: https://www.polarismarketresearch.com  
Follow US: LinkedIn | twitter

SOURCE Polaris Market Research

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.